4511 - 4520 of 7785 Results
Title
Year
-
RESTRICTEDTitle: Dopamine Metabolism May Have Unexpected Benefits for Mitochondrial Energy ProductionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 562End Page: 562Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28005Citation Count: 0
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020RESTRICTEDTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 59
- Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease2020RESTRICTEDTitle: Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008677Best OA location URL: https://europepmc.org/articles/pmc7176296?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: Soluble TREM2 is elevated in Parkinson’s disease subgroups with increased CSF tauJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 3Start Page: 932End Page: 943Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa021Best OA location URL: https://academic.oup.com/brain/article-pdf/143/3/932/32963580/awaa021.pdfCitation Count: 54
-
RESTRICTEDTitle: The Discovery of LRRK2 Mutations as a Cause of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 551End Page: 554Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27999Citation Count: 5
- Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRI2020RESTRICTEDTitle: Brain perfusion patterns are altered in chronic knee pain: a spatial covariance analysis of arterial spin labelling MRIJournal Name: PainPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 161Issue #: 6Start Page: 1255End Page: 1263Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1097/j.pain.0000000000001829Best OA location URL: https://journals.lww.com/pain/Fulltext/2020/06000/Brain_perfusion_patterns_are_altered_in_chronic.13.aspxCitation Count: 17
- LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis2020RESTRICTEDTitle: LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.51071Best OA location URL: https://doi.org/10.7554/elife.51071Citation Count: 83
-
RESTRICTEDTitle: Pathology‐Proven Corticobasal Degeneration Presenting as Richardson's SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 267End Page: 272Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12900Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12900Citation Count: 7
- Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa2020RESTRICTEDTitle: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of LevodopaJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2020Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/9716317Best OA location URL: https://doi.org/10.1155/2020/9716317Citation Count: 13
-
RESTRICTEDTitle: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-59414-4Best OA location URL: https://www.nature.com/articles/s41598-020-59414-4.pdfCitation Count: 59